Healthcare / BiotechnologyNasdaqGS
$4.86
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 24%
FCF escenarios
weak_data · normalized FCF $-103.7M · quality 52.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
1/100
F
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$387M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-145.0%
↓Gross Margin
N/A
•Debt/Equity
N/A
•Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2019–2025 · 6 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
—
FCF margin
-464.3%
FCF / Net income
0.57x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $12.1M · net income $-99.5M · FCF $-56.4M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | $12.1M | $12.1M | $7.0M | — | — | — | — | — |
| Net Income | $-99.5M | $-99.5M | $-127.2M | $-121.8M | $-115.4M | $-111.7M | $-56.9M | $-27.6M |
| EBITDA | $-102.9M | $-102.9M | $-137.9M | $-131.1M | $-122.2M | $-112.8M | $-58.2M | $-27.7M |
| EPS | -1.29 | -1.29 | -1.68 | -2.02 | -2.44 | -2.43 | — | — |
| Operating Margin | -861.3% | -861.3% | -1995.9% | — | — | — | — | — |
| Net Margin | -819.6% | -819.6% | -1816.8% | — | — | — | — | — |
| Cash Flow | ||||||||
| Free Cash Flow | $-56.4M | $-56.4M | $-103.7M | $-110.6M | $-86.7M | $-85.9M | $-46.8M | $-26.4M |
| Returns | ||||||||
| ROE | -145.0% | -145.0% | -96.7% | -51.4% | -59.1% | -39.1% | -26.8% | 55.8% |
| Growth & Yield | ||||||||
| Revenue Growth | 73.4% | 73.4% | — | — | — | — | — | — |
| EPS Growth | 23.2% | 23.2% | 16.8% | 17.2% | -0.4% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Unavailable: positive start/end prices are required.